To examine the pathological and clinical features associated with cfDNA ESR1 and PIK3CA mutations in the 113 ER + /HER-cases, we looked at differences in the clinical features of the breast cancer between patients who had and did not have detectable ESR1 or PIK3CA mutations in cfDNA. The gene discussed is PIK3CA; the disease is breast carcinoma.